Literature DB >> 8195882

Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.

S Takikawa1, V Dhawan, T Chaly, W Robeson, R Dahl, I Zanzi, F Mandel, P Spetsieris, D Eidelberg.   

Abstract

UNLABELLED: PET has been used to quantify striatal 6-[18F]fluoro-L-dopa (FDOPA) uptake as a measure of presynaptic dopaminergic function. Striatal FDOPA uptake rate constants (Ki) can be calculated using dynamic PET imaging with measurements of the plasma FDOPA input function determined either directly or by several estimation procedures.
METHODS: We assessed the comparative clinical utility of these methods by calculating the striato-occipital ratio (SOR) and striatal Ki values in 12 patients with mild to moderate PD and 12 age-matched normal volunteers. The plasma FDOPA time-activity curve (KiFD); the plasma 18F time-activity curve (KiP); the occipital time-activity curve (KiOCC); and a simplified population-derived FDOPA input function (KiEFD) were used to calculate striatal Ki.
RESULTS: Mean values for all striatal Ki estimates and SOR were significantly lower in the PD group. Although all measured parameters discriminated PD patients from normals, KiFD and KiEFD provided the best between-group separation. KiFD, KiEFD and KiOCC measures correlated significantly with quantitative disease severity ratings, although KiFD predicted quantitative clinical disability most accurately.
CONCLUSION: These results suggest that KiFD may be an optimal marker of the parkinsonian disease process. KiEFD may be a useful alternative to KiFD for most clinical research applications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195882

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies.

Authors:  Paolo Zanotti-Fregonara; Renaud Maroy; Marie-Anne Peyronneau; Régine Trebossen; Michel Bottlaender
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-10       Impact factor: 9.236

Review 2.  Image-derived input function for brain PET studies: many challenges and few opportunities.

Authors:  Paolo Zanotti-Fregonara; Kewei Chen; Jeih-San Liow; Masahiro Fujita; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-03       Impact factor: 6.200

3.  Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

Authors:  P K Morrish; J S Rakshi; D L Bailey; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

Review 4.  Presynaptic dopamine in schizophrenia.

Authors:  Nobumi Miyake; Judy Thompson; Mette Skinbjerg; Anissa Abi-Dargham
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

5.  Comparison of Invasive and Non-invasive Estimation of [11C]PBR28 Binding in Non-human Primates.

Authors:  Lucero Aceves-Serrano; Vesna Sossi; Doris J Doudet
Journal:  Mol Imaging Biol       Date:  2021-10-07       Impact factor: 3.488

6.  Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder.

Authors:  Paolo Zanotti-Fregonara; Christina S Hines; Sami S Zoghbi; Jeih-San Liow; Yi Zhang; Victor W Pike; Wayne C Drevets; Alan G Mallinger; Carlos A Zarate; Masahiro Fujita; Robert B Innis
Journal:  Neuroimage       Date:  2012-08-10       Impact factor: 6.556

7.  Influence of O-methylated metabolite penetrating the blood-brain barrier to estimation of dopamine synthesis capacity in human L-[β-(11)C]DOPA PET.

Authors:  Keisuke Matsubara; Yoko Ikoma; Maki Okada; Masanobu Ibaraki; Tetsuya Suhara; Toshibumi Kinoshita; Hiroshi Ito
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

8.  Clinical and [18F] dopa PET findings in early Parkinson's disease.

Authors:  P K Morrish; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

9.  Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats.

Authors:  Kiyoshi Kyono; Tadayuki Takashima; Yumiko Katayama; Toshiyuki Kawasaki; Riyo Zochi; Maki Gouda; Yasuhiro Kuwahara; Kazuhiro Takahashi; Yasuhiro Wada; Hirotaka Onoe; Yasuyoshi Watanabe
Journal:  EJNMMI Res       Date:  2011-11-10       Impact factor: 3.138

10.  Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies.

Authors:  Paolo Zanotti-Fregonara; Jussi Hirvonen; Chul Hyoung Lyoo; Sami S Zoghbi; Denise Rallis-Frutos; Marilyn A Huestis; Cheryl Morse; Victor W Pike; Robert B Innis
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.